glp-1 side effects pancreatitis Updates in Medicine | GLP-1s may raise risk early—but over time, protective balance the scale, resulting in no increase in overall 1-year risk Experts demand study into weight
Description
The World Health Organization (WHO) requested these reviews to help shape upcoming recommendations on using these medications for obesity treatment
[DOI] [PMC free article] [PubMed] [Google Scholar] 283.Ma J., Chang J., Checklin H.L., Young R.L., Jones K.L., Horowitz M
298: 194206 [DOI] [PubMed] [Google Scholar] 170.Kikuchi M, Abe N, Kato M, et al
Understanding GLP-1 as part of a larger hormonal system helps explain why supporting it naturally may work well for some people, while others need additional medical support
Rate of weight loss over time Weight loss was not linear
But most patients drop off the drugs before one year: Among GLP-1 patients with obesity who fill their first prescription, just 32% are still taking their medication 13 months later, per November IQVIA analysis
